5-Pregnanetriol (5PT), also known as 5-pregnene-3β,17α,20α-triol, is a urinary metabolite of 17α-hydroxypregnenolone, reflecting the downstream metabolism of steroid hormones.
Its detection and levels in urine offer insights into steroid biosynthesis and metabolism, assisting in the assessment of endocrine functions.
Elevated 5PT levels indicate deficiencies in the enzyme 21-hydroxylase, associated with congenital adrenal hyperplasia (CAH), a genetic disorder affecting adrenal steroidogenesis.
This elevation results from the accumulation of upstream steroid precursors diverted into alternative pathways due to impaired 21-hydroxylase activity, making 5PT a valuable biochemical marker for diagnosing and monitoring CAH and related conditions.
5-Pregnanetriol, also known as 5PT and as 5-pregnene-3β,17α,20α-triol, is a urinary metabolite of 17α-hydroxypregnenolone.
The detection of 5PT in urine reflects the downstream metabolism of steroid hormones, specifically indicating the conversion pathways active in steroidogenic tissues. Its presence and levels in urine provide insights into steroid biosynthesis and metabolism, assisting in the assessment of endocrine functions and potential disruptions.
Elevated levels of 5-pregnanetriol (5PT) specifically indicate deficiencies in the enzyme 21-hydroxylase. This enzyme deficiency is associated with congenital adrenal hyperplasia (CAH), a group of genetic disorders affecting adrenal steroidogenesis.
Elevated 5PT levels are a result of the accumulation of upstream steroid precursors, which are diverted into alternative pathways due to the impaired activity of 21-hydroxylase.
21-hydroxylase is an enzyme critical in the biosynthesis of cortisol and aldosterone in the adrenal glands. It catalyzes the conversion of 17α-hydroxyprogesterone to 11-deoxycortisol and progesterone to 11-deoxycorticosterone.
When 21-hydroxylase is deficient, as in congenital adrenal hyperplasia (CAH), the pathway leading to cortisol and aldosterone synthesis is blocked. This results in the accumulation of precursor steroids, which are then diverted into alternative metabolic pathways, leading to the production of excess androgenic steroids and their metabolites.
One of these alternative pathways results in the increased production of 17α-hydroxypregnenolone, which is further converted to 5-pregnenetriol (5PT).
Therefore, elevated levels of 5PT in urine can be a biochemical marker indicating a deficiency in 21-hydroxylase, as it reflects the accumulation and shunting of steroid precursors away from the blocked 21-hydroxylase-dependent pathways.
CAH is primarily caused by 21-hydroxylase deficiency, leading to more than 90% of CAH cases. Early diagnosis and treatment are vital to prevent complications like genital virilization in females and adrenal insufficiency in males.
Newborn screening programs help identify affected infants by measuring 17-hydroxyprogesterone, and sometimes pregnanetriol, levels. They may also be tested in amniotic fluid.
Normally, steroid 21-hydroxylase (CYP21, P450c21) hydroxylates 17-hydroxyprogesterone and progesterone to produce cortisol and aldosterone precursors.
Deficiency in this enzyme leads to cortisol and aldosterone deficiencies, resulting in high ACTH levels, adrenal hyperplasia, and overproduction of cortisol precursors, some of which convert to sex steroids.
Accordingly, elevated 17-hydroxyprogesterone, pregnanetriol, and other metabolites including 5-pregnanetriol can also be seen.
The main symptoms of congenital adrenal hyperplasia caused by 21-hydroxylase deficiency are due to lack of cortisol (leading to salt-wasting crisis), lack of aldosterone (salt-wasting), and excess androgens causing virilization in females and premature puberty in both sexes. [7.]
Severity depends on the degree of 21-hydroxylase deficiency. [7.]
Classic Salt-Wasting Form:
Classic Simple Virilizing Form:
Non-Classic Form:
Low levels of 17-hydroxyprogesterone (17-OHP) and pregnanetriol can be indicative of adrenal insufficiency.
17-OHP is an intermediate in the adrenal biosynthetic pathway from cholesterol to cortisol. It is converted to cortisol in the adrenal glands via the enzyme steroid 21-hydroxylase.
In cases of adrenal insufficiency, the production of 17-OHP and its downstream metabolites, including pregnanetriol, is diminished due to impaired adrenal function.
This impairment can be due to inherited enzyme deficiencies or other conditions affecting adrenal health, leading to insufficient cortisol synthesis and consequently low levels of 17-OHP and pregnanetriol in the body.
Symptoms of untreated adrenal insufficiency or adrenal crisis include severe weakness, low blood pressure, low blood glucose, vomiting, diarrhea, confusion, darkening of the skin, shock and coma. [3.] Fertility issues can also be seen.
Low 5-pregnanetriol levels may also be seen with decreased endogenous progesterone production.
5-pregnanetriol levels are most commonly assessed in urine, typically over a 24 hour period. Serum tests may also be done. Urine sample collection is typically done at home, although it may be done in some clinical settings.
Blood samples require a venipuncture.
Newborn screening for 21-hydroxylase deficiency is typically done by assessing 17-OH-progesterone levels in blood.
It is important to consult with the ordering physician prior to sample collection, as certain medications or supplements may need to be avoided during collection.
Interpreting the results of 5-Pregnanetriol tests should be done within the broader context of an individual’s health history, symptoms, and a complete hormone panel. Normal 5-Pregnanetriol levels can vary based on age, sex, and physiological conditions.
One laboratory company reports an optimal range of 5-pregnanetriol levels as: 0.6-2.5 micromol/24 hour. [4.]
Elevated 5-pregnanetriol is most often seen in conditions like congenital adrenal hyperplasia due to 21-hydroxylase deficiency; elevated levels of 17-OH progesterone are also seen in this setting.
In patients supplementing with progesterone who have elevated 5-pregnanetriol levels, levels of other progesterone metabolites should be assessed, as well as progesterone levels in saliva and/or serum, to determine whether the individual is receiving excessive amounts of the hormone.
Low urinary 5-pregnanetriol may indicate adrenal insufficiency or low progesterone production.
Measurement of steroid hormone metabolites can provide valuable insights into the body's metabolic processes.
Testing for progesterone metabolites such as 17-hydroxyprogesterone as well as alpha- and beta-pregnanediol may provide additional insight. Other hormones to consider include estrogen and its main metabolites such as 2-hydroxy and 4-hydroxy metabolites and 16-hydroxyestrone.
Testosterone may be assessed in conjunction with other androgens including 5-dihydrotestosterone, DHEA-S, etiocholanolone, androsterone and androstanedione in order to understand the balance of sex hormones.
Cortisol and its metabolites are adrenal steroid hormones, and these hormones may be assessed by testing cortisol and cortisone and their metabolites including 5-alpha-tetrahydrocortisol, 5-beta-tetrahydrocortisol, 5-alpha-tetrahydrocorticosterone and 5-beta-tetrahydrocorticosterone.
By evaluating these metabolites together, clinicians can identify specific enzyme defects, understand hormonal imbalances, and tailor treatment strategies more effectively.
The FAQ section addresses common questions and concerns about 5-Pregnanetriol, providing quick and clear answers for better understanding.
5-Pregnanetriol is a metabolite of progesterone, a hormone produced in the adrenal glands and gonads. It can be measured to assess adrenal function and certain hormonal disorders.
5-Pregnanetriol is important because its levels can indicate abnormalities in steroid hormone metabolism. Elevated or decreased levels of 5-Pregnanetriol can be associated with various health conditions, including congenital adrenal hyperplasia (CAH) and other hormonal imbalances.
The 5-Pregnanetriol test measures the levels of this metabolite in the urine or blood. This test is used primarily to diagnose and monitor conditions related to abnormal steroid hormone production, such as congenital adrenal hyperplasia (CAH).
The 5-Pregnanetriol test typically involves collecting a urine sample over a 24-hour period or a single blood sample. The sample is then analyzed in a laboratory to determine the concentration of 5-Pregnanetriol.
Normal levels of 5-Pregnanetriol can vary depending on factors such as age, sex, and health status. Reference ranges are established by individual laboratories, and results should be interpreted by a healthcare provider in the context of the patient’s overall health and medical history.
Elevated levels of 5-Pregnanetriol are often associated with congenital adrenal hyperplasia (CAH), a genetic disorder affecting adrenal gland function. Other possible causes include excessive production or supplementation of progesterone.
Low levels of 5-Pregnanetriol may indicate adrenal insufficiency. It may also be associated with decreased progesterone levels, although further testing of progesterone as well as its metabolites should be done as part of further assessment.
Symptoms of abnormal 5-Pregnanetriol levels can vary depending on the underlying condition.
High levels may be associated with symptoms of CAH, such as ambiguous genitalia in newborns, early onset of puberty, and excessive hair growth.
Low levels may lead to symptoms of adrenal insufficiency such as fatigue, muscle weakness, and low blood pressure.
Treatment for abnormal 5-Pregnanetriol levels depends on the underlying cause.
For conditions like congenital adrenal hyperplasia (CAH), treatment may include hormone replacement therapy to balance steroid hormone levels.
Managing adrenal insufficiency typically involves glucocorticoid and mineralocorticoid replacement.
Yes, the 5-Pregnanetriol test is safe. The most common risk is slight discomfort or bruising at the site where blood is drawn if a blood sample is taken. Urine collection is non-invasive and generally risk-free.
A doctor might order a 5-Pregnanetriol test if there are symptoms suggestive of congenital adrenal hyperplasia (CAH) or other adrenal gland disorders.
It can also be part of a diagnostic workup for unexplained symptoms related to hormone imbalance.
Click here to compare testing options and order tests to assess steroid metabolite levels.
[1.] Burdea L, Mendez MD. 21-Hydroxylase Deficiency. [Updated 2023 Jul 31]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK493164/
[2.] Chang, H., Meng, Hy., Liu, Sm. et al. Identification of key metabolic changes during liver fibrosis progression in rats using a urine and serum metabolomics approach. Sci Rep 7, 11433 (2017). https://doi.org/10.1038/s41598-017-11759-z
[3.] Elshimy G, Chippa V, Kaur J, et al. Adrenal Crisis. [Updated 2023 Sep 13]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK499968/
[4.] Genova Diagnostics. Patient: SAMPLE PATIENT DOB: Sex: MRN: Physician Copy. https://www.gdx.net/core/sample-reports/Complete-Hormones-24hr-Sample-Report.pdf
[5.] Honour JW. 17-Hydroxyprogesterone in children, adolescents and adults. Annals of Clinical Biochemistry. 2014;51(Pt 4):424-440. doi:https://doi.org/10.1177/0004563214529748
[6.] Schiffer L, Barnard L, Baranowski ES, Gilligan LC, Taylor AE, Arlt W, Shackleton CHL, Storbeck KH. Human steroid biosynthesis, metabolism and excretion are differentially reflected by serum and urine steroid metabolomes: A comprehensive review. J Steroid Biochem Mol Biol. 2019 Nov;194:105439. doi: 10.1016/j.jsbmb.2019.105439. Epub 2019 Jul 27. PMID: 31362062; PMCID: PMC6857441.
[7.] What are the symptoms of congenital adrenal hyperplasia (CAH)? https://www.nichd.nih.gov/. https://www.nichd.nih.gov/health/topics/cah/conditioninfo/symptoms